Fda Alerts Article Listing | RxWiki

FDA Alerts

New Psoriatic Arthritis Rx Gets FDA Approval

The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA).

REFINE

conditions
- - (-) Remove Rheumatic Disease filter Rheumatic Disease
    (-) Remove Psoriatic Arthritis filter Psoriatic Arthritis